TREATMENT FOR EYE DISORDER
    1.
    发明申请
    TREATMENT FOR EYE DISORDER 有权
    治疗眼病

    公开(公告)号:US20080286255A1

    公开(公告)日:2008-11-20

    申请号:US12126100

    申请日:2008-05-23

    IPC分类号: A61K38/43 A61P27/02

    摘要: The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment of any eye disorder, although in particular embodiments the individual has a thickened Bruch's membrane. An activating energy source is utilized to effect a controlled diffusion enhancement and/or degradation of Bruch's membrane that enables improved diffusional transport between the choroid and retina. The individual is administered an inactivated diffusion-enhancing molecule that becomes associated with the membrane, which is then precisely exposed to an activating energy source, such as light or ultrasound.

    摘要翻译: 本发明涉及改变眼睛中至少一个组织的至少一部分的物理和/或化学性质。 在具体实施方案中,它涉及任何眼睛疾病的治疗,尽管在具体实施方案中个体具有增厚的布鲁赫氏膜。 使用活化能源来实现Bruch膜的受控扩散增强和/或降解,其能够改善脉络膜和视网膜之间的扩散转运。 给个体施用与膜相关的失活的扩散增强分子,然后将其精确地暴露于诸如光或超声的活化能源。

    Treatment for eye disorder
    2.
    发明授权
    Treatment for eye disorder 有权
    治疗眼病

    公开(公告)号:US08298521B2

    公开(公告)日:2012-10-30

    申请号:US12126100

    申请日:2008-05-23

    IPC分类号: A61K31/74

    摘要: The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment of any eye disorder, although in particular embodiments the individual has a thickened Bruch's membrane. An activating energy source is utilized to effect a controlled diffusion enhancement and/or degradation of Bruch's membrane that enables improved diffusional transport between the choroid and retina. The individual is administered an inactivated diffusion-enhancing molecule that becomes associated with the membrane, which is then precisely exposed to an activating energy source, such as light or ultrasound.

    摘要翻译: 本发明涉及改变眼睛中至少一个组织的至少一部分的物理和/或化学性质。 在具体实施方案中,它涉及任何眼睛疾病的治疗,尽管在具体实施方案中个体具有增厚的布鲁赫氏膜。 使用活化能源来实现Bruch膜的受控扩散增强和/或降解,其能够改善脉络膜和视网膜之间的扩散转运。 给个体施用与膜相关的失活的扩散增强分子,然后将其精确地暴露于诸如光或超声的活化能源。

    Treatment for dry macular degeneration
    3.
    发明授权
    Treatment for dry macular degeneration 有权
    治疗干性黄斑变性

    公开(公告)号:US07381404B2

    公开(公告)日:2008-06-03

    申请号:US10611013

    申请日:2003-07-01

    IPC分类号: A61K31/74

    摘要: The present invention relates to altering the physical and/or chemical properties of at least part of at least one tissue in the eye. In a specific embodiment, it relates to the treatment of any eye disorder, although in particular embodiments the individual has a thickened Bruch's membrane. An activating energy source is utilized to effect a controlled diffusion enhancement and/or degradation of Bruch's membrane that enables improved diffusional transport between the choroid and retina. The individual is administered an inactivated diffusion-enhancing molecule that becomes associated with the membrane, which is then precisely exposed to an activating energy source, such as light or ultrasound.

    摘要翻译: 本发明涉及改变眼睛中至少一个组织的至少一部分的物理和/或化学性质。 在具体实施方案中,它涉及任何眼睛疾病的治疗,尽管在具体实施方案中个体具有增厚的布鲁赫氏膜。 使用活化能源来实现Bruch膜的受控扩散增强和/或降解,其能够改善脉络膜和视网膜之间的扩散转运。 给个体施用与膜相关的失活的扩散增强分子,然后将其精确地暴露于诸如光或超声的活化能源。